COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak

BACKGROUND: We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed. METHODS: Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonomo, Antonio, Brescia Morra, Vincenzo, Zappulo, Emanuela, Lanzillo, Roberta, Gentile, Ivan, Montella, Emma, Triassi, Maria, Palladino, Raffaele, Moccia, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283048/
https://www.ncbi.nlm.nih.gov/pubmed/32554288
http://dx.doi.org/10.1016/j.msard.2020.102282
Descripción
Sumario:BACKGROUND: We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed. METHODS: Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS). RESULTS: We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and have also included 14-day self-isolation and COVID-19 testing before some disease modifying treatments. DISCUSSION: Overall, we believe our experience could be helpful for MS management in the upcoming months.

Ejemplares similares